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suppression when used with ritonavir/lopinavir. HIV-infected 
children have a high incidence of chronic lung disease, which 
includes chronic obstructive respiratory disease.5 Given 
the large number of children who are prescribed ritonavir-
containing antiretroviral regimens, many may be exposed to 
co-treatment with budesonide.
The daily dose of budesonide used in our cases varied 
from 200 µg to 1 200 µg. Adherence to medication was 
assessed by verbal report and medication demonstration by 
the caregiver. In case 2 the child was given medication by 
a trained nurse in a children’s home and medication was 
boarded for us to review. Dosing of inhaled budesonide in 
children with obstructive lung disease is based on clinical 
response to treatment. Recommended dosing ranges from 
a low dose of 100 - 200 µg/d to higher doses of >400 µg/d. 
With the exception of case 1 these children were on moderate 
doses of budesonide only and in case 3 initially a low dose 
of fluticasone (50 µg/d). The fact that the children may have 
been overdosed cannot be entirely excluded. However, it 
appears that adrenal axis suppression can occur at standard 
recommended doses of budesonide and fluticasone when used 
concomitantly with ritonavir. This relationship requires further 
investigation.
The older nucleoside reverse transcriptase inhibitors (NRTIs) 
such as zidovudine and stavudine remain first-line therapy 
in our and other resource-limited settings. These drugs 
are associated with lipodystrophy and truncal obesity. It is 
important to consider Cushing’s syndrome as a differential 
diagnosis and that the diagnosis of adrenal suppression is not 
missed.6 
The combination of ritonavir and inhaled corticosteroids 
should be avoided. If co-therapy is necessary, careful physical 
examination and monitoring of adrenal axis function are 
essential. 
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High prevalence of hookah smoking among secondary 
school students in a disadvantaged community in 
Johannesburg
A Combrink, N Irwin, G Laudin, K Naidoo, S Plagerson, A Mathee
To the Editor: Smoking of hookahs (also known as water-pipes) 
represents an emerging trend in tobacco use.1 Hookah smokers 
are at risk for the same diseases caused by cigarette smoking – 
cancer, respiratory and heart diseases, and pregnancy-related 
complications. Globally, the highest rates occur in the North 
African and East Mediterranean regions and among young 
people in the USA and European countries.2 There has been 
little research on hookah smoking in southern Africa.
Methods
The Health, Environment and Development study,3 conducted 
by the South African Medical Research Council in five 
deprived areas of Johannesburg, observed surprisingly 
high rates of smoking in a community near the centre of 
Johannesburg. Anecdotal reports and direct observations 
pointed to a high frequency of hookah smoking as a possible 
explanation. Subsequently, undergraduate medical students of 
the University of the Witwatersrand were invited to conduct a 
health education workshop on the effects of hookah smoking 
in the secondary school serving this community. To inform the 
workshop, a baseline survey was conducted among the student 
population. All Grade 10 students were invited to participate. 
Approval to conduct the study was obtained from the school 
principal, and verbal consent was obtained from the individual 
students, following an explanation that the study was 
voluntary and anonymous and that the results would be used 
for research purposes only. The ages of participants (N=202) 
in the four classes were from 14 - 20 years (mean 16.3 years). 
Three students elected not to participate.
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Results
The survey findings are summarised in Table I; 72% of 
respondents reported having used a tobacco product, including 
over 60% who said they had used or were using hookahs at 
the time of the study. A third of hookah users and a fifth of 
the entire sample reported daily use. Most respondents started 
smoking hookahs between the ages of 13 and 15, while 21% 
had started when ≤12 years old. The most common setting for 
smoking was social occasions (such as parties), with many also 
reporting home use. While the norm was to use tobacco in the 
hookah, significant numbers also reported using marijuana 
and/or alcohol-based products in combination with tobacco. 
Almost 10% of the total sample reported using marijuana in 
hookahs. The most common reason for smoking a hookah was 
the absence of alternative recreation (‘nothing better to do’); 
other reasons were peer pressure, relaxation and addiction.
Among non-users, the vast majority said they would not 
consider smoking a hookah in the future; however, 39% had 
been subjected to pressure from peers to do so. Hookahs were 
perceived to be safer than cigarettes by most users, but as 
equally unsafe by the majority of non-users.
Discussion
The survey highlighted an alarmingly high rate of hookah 
use among the schoolchildren surveyed. Sixty per cent of 
study participants reported use of a hookah, including 20% 
who reported daily use, which is comparable with the rates 
observed among youths in settings where the use of hookahs is 
traditional.4 Our survey further highlighted the commencement 
of hookah use at a young age and the widespread use of 
tobacco in combination with substances such as alcohol 
and marijuana. In line with studies conducted elsewhere, 
the survey points to a widely held belief among users that 
hookah smoking is less harmful than other forms of smoking.5 
Nevertheless, levels of awareness of the equally damaging 
effects to health of cigarettes and hookahs were higher among 
non-users.
Table I. Smoking patterns among secondary school students
      Hookah users (N=123) Hookah non-users (N=79)         Total (N=202)
              N        %          N           %      N    % 
Smokers (any tobacco product) 
Cigarettes               61   30.2
Hookah               123   60.9
Other tobacco products              15   7.4
Any tobacco product              146   72.3
Frequency of hookah use 
 Tried only once or twice           38        30.9         38   18.8
Weekly or less            43        35.0         43   21.3
Daily              41        33.3         41   20.3
Age of first use (years) 
 <10              5        4.1         5   2.5
10 - 12              21        17.1         21   10.4
13 - 15              62        50.4         62   30.7
16 - 18              34        27.6         34   16.8
Setting of use
 At home             47        38.2         47   23.3
At school            3        2.4         3   1.5
Public places (e.g. cafes)           6        4.9         6   3.0
At parties/with friends           76        61.8         76   37.6
Substance in hookah 
 Tobacco only            41        33.3         41   20.3
Tobacco and marijuana           19        15.4         19   9.4
Tobacco and alcohol/spirits          13        10.6         13   6.4
Reasons for smoking
 Peer pressure            17        13.8         17   8.4
‘Helps to relax’            34        27.6         34   16.8
‘Nothing better to do’           56        45.5         56   27.7
Addicted            8        6.5         8   4.0
Openness to future use
 Yes                 6          7.6      6   3.0
No                 73          92.4      73   36.1
Perceived pressure to smoke hookah
 Yes                 31           39.2     31   15.3
No                 43           54.4     43   21.3
Hookah perceived as
 Safer to smoke than cigarettes          65        52.8          8           10.1     65   32.2
Less safe than cigarettes           8        6.5          9           11.4     8   4.0
Equally unsafe as cigarettes           52        42.3          51           64.6     52   25.7
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Though conducted on a small scale, our study plays an 
important role in bringing to light the disturbingly high 
prevalence of hookah smoking in one community, and points 
to an urgent need to conduct research on a nation-wide basis 
to determine the extent of hookah smoking in South Africa 
and the factors associated with its use. The reasons given by 
participants for commencing hookah smoking (e.g. boredom 
and a lack of recreational opportunities) imply a probable need 
for social and public health interventions that provide safer 
recreational alternatives to urban youth in Johannesburg and 
very likely elsewhere in South Africa.
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